On-demand education
Filter
FILTER BY TESTS
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Non-Dysplastic Barrett’s Esophagus: A Spatial-Temporal Analysis

October 20, 2001
Assessing additional spatial and temporal biopsies increased the predictive accuracy, allowing for identification of most future progressors.
TissueCypher
Barrett's Esophagus
Authors: Nicola F Frei
Prognostic
Gastroenterology
Publication

Independent Blinded Validation of a Tissue Systems Pathology Test to Predict Progression in Patients with Barrett’s Esophagus

June 20, 2001
A risk prediction test identifies patients with non-dysplastic Barrett's esophagus who are at high risk for progression to high-grade dysplasia or cancer.
TissueCypher
Barrett's Esophagus
Authors: Jon M Davison
Prognostic
Gastroenterology
Publication

Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res 2007;3(5):1466-71.

DecisionDx-UM
Authors: Worley LA, Onken MD, Person E, et al.
Prognostic
Ophthalmology

Uveal melanomas with SF3B1 Mutations: a distinct subclass associated with late-onset metastases. Ophthalmology 2016;123:1118-28.

DecisionDx-UM
Authors: Yavuzyigitoglu S, Koopmans AE, Verdijk RM, et al.
Prognostic
Ophthalmology

Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications. Graefes Arch Clin Exp Ophthalmol 2014;252(1):131-5.

DecisionDx-UM
Authors: Correa ZM & Augsburger JJ.
Prognostic
Ophthalmology

Uveal melanoma: molecular pattern, clinical features, and radiation response. Am J Ophthalmol 2012;154(2):227-32.

DecisionDx-UM
Authors: Chappell MC, Char DH, Cole TB, et al
Prognostic
Ophthalmology

Uveal melanoma prognostication: from lesion size and cell type to molecular class. Can J Ophthalmol 2012;47:246-253.

DecisionDx-UM
Authors: Gill HS & Char DH.
Prognostic
Ophthalmology

The DecisionDx-UM gene expression profile test provides risk stratification and individualized patient care in uveal melanoma. PLoS Curr 2013. doi: 10.1371/currents.eogt.af8ba80fc776c8f1ce8f5dc485d4a618.

DecisionDx-UM
Authors: Harbour JW & Chen R.
Prognostic
Ophthalmology

Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling. Melanoma Manag 2020;7(1):MMT37.

DecisionDx-UM
Authors: Schefler AC, Skalet A, Oliver SCN, et al.
Prognostic
Ophthalmology

PRAME as an independent biomarker for metastasis in uveal melanoma. Clin Cancer Res 2016;22(5):1234-42.

DecisionDx-UM
Authors: Field MG, Decatur CL, Kurtenbach S, et al.
Prognostic
Ophthalmology

Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 2008;49:5230-4.

DecisionDx-UM
Authors: Onken MD, Worley LA, Long MD, et al.
Prognostic
Ophthalmology

Prognostic implications of tumor diameter in association with gene expression profile for uveal melanoma. JAMA Ophthalmol 2016;134(7):734-40.

DecisionDx-UM
Authors: Walter SD, Chao DL, Feuer W, et al.
Prognostic
Ophthalmology